|
Name |
(12Z)-9,10-Dihydroxyoctadec-12-enoate
|
Molecular Formula | C18H34O4 | |
IUPAC Name* |
(Z,9R,10R)-9,10-dihydroxyoctadec-12-enoic acid
|
|
SMILES |
CCCCC/C=C\C[C@H]([C@@H](CCCCCCCC(=O)O)O)O
|
|
InChI |
InChI=1S/C18H34O4/c1-2-3-4-5-7-10-13-16(19)17(20)14-11-8-6-9-12-15-18(21)22/h7,10,16-17,19-20H,2-6,8-9,11-15H2,1H3,(H,21,22)/b10-7-/t16-,17-/m1/s1
|
|
InChIKey |
XEBKSQSGNGRGDW-GJWDQICYSA-N
|
|
Synonyms |
(+/-)-Threo-9,10-dihydroxy-12(Z)-octadecenoic acid; 263399-34-4; 9,10-DiHOME; 9,10-hydroxyoctadec-12(Z)-enoic acid; (12Z)-9,10-Dihydroxyoctadec-12-enoate; DTXSID701346557; 9,10-dihydroxy-12Z-octadecenoate; 9,10-hydroxyoctadec-12(Z)-enoate; ZINC12496444; threo-9,10-Dihydroxy-12(Z)-octadecenoic acid; (9R,10R,12Z)-9,10-Dihydroxy-12-octadecenoic acid; (9R,10R,12Z)-9,10-DIHYDROXYOCTADEC-12-ENOIC ACID
|
|
CAS | 263399-34-4 | |
PubChem CID | 25320862 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 314.5 | ALogp: | 4.6 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.8 | Aromatic Rings: | 0 |
Heavy Atoms: | 22 | QED Weighted: | 0.303 |
Caco-2 Permeability: | -5.258 | MDCK Permeability: | 0.00005110 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.033 |
Human Intestinal Absorption (HIA): | 0.175 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.475 | Plasma Protein Binding (PPB): | 96.44% |
Volume Distribution (VD): | 0.542 | Fu: | 1.30% |
CYP1A2-inhibitor: | 0.072 | CYP1A2-substrate: | 0.187 |
CYP2C19-inhibitor: | 0.02 | CYP2C19-substrate: | 0.109 |
CYP2C9-inhibitor: | 0.047 | CYP2C9-substrate: | 0.988 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.205 |
CYP3A4-inhibitor: | 0.011 | CYP3A4-substrate: | 0.017 |
Clearance (CL): | 3.955 | Half-life (T1/2): | 0.916 |
hERG Blockers: | 0.07 | Human Hepatotoxicity (H-HT): | 0.084 |
Drug-inuced Liver Injury (DILI): | 0.013 | AMES Toxicity: | 0.016 |
Rat Oral Acute Toxicity: | 0.014 | Maximum Recommended Daily Dose: | 0.037 |
Skin Sensitization: | 0.876 | Carcinogencity: | 0.067 |
Eye Corrosion: | 0.095 | Eye Irritation: | 0.819 |
Respiratory Toxicity: | 0.255 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001099 | 0.672 | D0O1PH | 0.568 | ||||
ENC001589 | 0.672 | D0O1TC | 0.531 | ||||
ENC001613 | 0.667 | D09SRR | 0.462 | ||||
ENC001554 | 0.631 | D0I4DQ | 0.461 | ||||
ENC001535 | 0.616 | D0UE9X | 0.457 | ||||
ENC001100 | 0.616 | D0Z5BC | 0.448 | ||||
ENC001555 | 0.616 | D0XN8C | 0.446 | ||||
ENC001419 | 0.616 | D06FEA | 0.413 | ||||
ENC001584 | 0.616 | D0OR6A | 0.406 | ||||
ENC001591 | 0.616 | D04RGA | 0.376 |